4 results match your criteria: "Department of Pathology University of Alabama at Birmingham Birmingham AL.[Affiliation]"

Article Synopsis
  • Alveolar hypoxia may help protect the heart from failure caused by left ventricular pressure overload (LVPO), although the specific mechanisms behind this protection are not fully understood.
  • A new mouse model (HxTAC) was created that combines chronic hypoxia with LVPO, showing resistance to heart failure and identifying key protective mechanisms such as enhanced angiogenesis and preserved metabolic function.
  • Findings suggest that hypoxia reduces the impact of LVPO-induced heart failure and may also play a role in recovery after heart failure treatments like left ventricular assist devices, highlighting its potential as a therapeutic target.
View Article and Find Full Text PDF

Background Lifestyle and metabolic diseases influence the severity and pathogenesis of cardiovascular disease through numerous mechanisms, including regulation via posttranslational modifications. A specific posttranslational modification, the addition of -linked β- acetylglucosamine (-GlcNAcylation), has been implicated in molecular mechanisms of both physiological and pathologic adaptations. The current study aimed to test the hypothesis that in cardiomyocytes, sustained protein -GlcNAcylation contributes to cardiac adaptations, and its progression to pathophysiology.

View Article and Find Full Text PDF

Recent studies have proven that long noncoding RNAs (lncRNAs) exhibit regulatory functions of both DNA damage response (DDR) and endoplasmic reticulum (ER) stress. Herein, ER stress-induced lncRNA transcriptomic changes are reported in human oral squamous cell carcinoma (OSCC) cells and a novel lncRNA ( nronic ranscript of tress) is identified as the most significantly upregulated lncRNA. It is shown that is a nucleus-located lncRNA including two transcript variants.

View Article and Find Full Text PDF

Intraventricular melanoma is a very rare and highly malignant disease. Safe resection is the mainstay of treatment, but no standard guidelines exist for adjuvant therapy. Early histologic and molecular diagnosis is key for improved survival.

View Article and Find Full Text PDF